Bracarda, S., Hutson, T. E., Porta, C., Figlin, R. A., Calvo, E., Grünwald, V., . . . Escudier, B. (2012). Everolimus in metastatic renal cell carcinoma patients intolerant to previous VEGFr-TKI therapy: A RECORD-1 subgroup analysis. Nature Publishing Group.
Citação norma ChicagoBracarda, S., et al. Everolimus in Metastatic Renal Cell Carcinoma Patients Intolerant to Previous VEGFr-TKI Therapy: A RECORD-1 Subgroup Analysis. Nature Publishing Group, 2012.
MLA citiranjeBracarda, S., et al. Everolimus in Metastatic Renal Cell Carcinoma Patients Intolerant to Previous VEGFr-TKI Therapy: A RECORD-1 Subgroup Analysis. Nature Publishing Group, 2012.
Opozorilo: Ti citati niso vedno 100% točni.